Episode summary
Major Indexes Test Resistance; Lindblad, Kiniksa Pharma, Guidewire In Focus | Stock Market Today
Summary
Major indexes were mixed as the NASDAQ Composite and NASDAQ 100 tested resistance at the 50-day moving average, while the S&P 500 and Dow held up better and the Russell 2000 showed more damage beneath its 200-day line. The hosts argued that the market is still in a tricky, rotational environment: tech and AI remain under pressure, but several non-tech groups are showing real strength.
They emphasized that the coming earnings wave could be pivotal for sentiment around AI spending and financing, especially with reports from mega-cap names approaching. The host said the market should be allowed to confirm whether AI stocks and chips are regaining leadership, rather than trying to force a bullish or bearish thesis.
Healthcare stood out as a bright spot, with XLV, XBI, and IBB all strong, and several individual names flashing actionable setups. Lindblad Expeditions, Kiniksa Pharma, and Guidewire were highlighted as constructive charts, while SpaceX was described as strong after its report. Netflix and Intuitive Surgical, by contrast, drew negative reactions and were seen as needing more repair work.
Key takeaways
- The hosts said the NASDAQ is still below key resistance, so the strongest read on the tape is caution rather than confirmation.
- Ed Carson argued that the market needs to prove AI and chip leadership again before investors lean aggressively into the space.
- Healthcare was one of the clearest areas of strength, with XLV up 2.4% and biotech ETFs also outperforming.
- Lindblad Expeditions, Kiniksa Pharma, and Guidewire all showed constructive price action and relative strength despite the weak broader tape.
- Netflix and Intuitive Surgical sold off after earnings, reinforcing that not every growth name is working even in a mixed market.
Notable quotes
“the major indexes mixed and testing resistance for the NASDAQ. a little bit of a roller coaster to nowhere”
“the NASDAQ is still really needs to get above there looks better uh you know for sure”
“if they give any hint of saying you know what it's not really paying off that great I get really ugly”
“there's a lot to like. So, you can't just get too bearish”
“this is clearly in the growth space. This is like strong growth uh top and bottom line”
Topics
- major indexes resistance
- stock watchlist
- lindblad
- kiniksa pharma
- guidewire
Companies and tickers mentioned
- GWRE
- Lindblad
- Kiniksa Pharma
- Guidewire Software
Watch the episode
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Stock Market Today With Ibd
-
Defense Key As Stocks Lose Ground; Humana, Appian, Sezzle In Focus | Stock Market Today -
Indexes Vulnerable At Key Levels; Toast, Docusign, Crocs In Focus | Stock Market Today -
Stocks Weather Nvidia News; Arista Networks, Five Below, Cloudflare In Focus | Stock Market Today -
Nasdaq Surges As AI Stocks Lead Tech Rebound; CRWV, AMD, TXN In Focus | Stock Market Today -
Indexes Fall As Consumer Prices Turn Hot: SEI Investments, FAST, FIVE In Focus | Stock Market Today -
Rebound Gets Stronger; Is It Enough? BrightSpring, Block In Focus | Stock Market Today
Stock Market Today With Ibd, this episode and its artwork belong to their owners. Octagon is not affiliated with the show; this page is an independent summary.